Alzheimer’s Deaths Prompt FDA to Tighten Lecanemab Rules

(MedPage Today) — The FDA will require earlier, additional MRI monitoring for Alzheimer’s disease patients taking lecanemab (Leqembi), an amyloid-directed treatment given by IV infusion, the agency said Thursday.
The agency called for the drug…